PURE Bioscience, Inc.
OTC: PURE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Robert F. Bartlett
- Employees
- 12
- Headquarters
- El Cajon, United States
- IPO year
- 1996
- Market cap
- $7.7M
- Website
- https://www.purebio.com
Loading PURE…
Loading profile data…Frequently asked questions about PURE
What does PURE Bioscience, Inc. (PURE) do?
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual pr...
Where does PURE trade?
PURE Bioscience, Inc. (PURE) trades on the Other OTC.
What sector is PURE in?
PURE Bioscience, Inc. (PURE) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of PURE Bioscience, Inc.?
Robert F. Bartlett is the chief executive officer of PURE Bioscience, Inc. (PURE).
Where is PURE Bioscience, Inc. headquartered?
PURE Bioscience, Inc. is headquartered in United States.
Does PURE pay a dividend?
PURE Bioscience, Inc. (PURE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PURE go public?
PURE Bioscience, Inc. (PURE) completed its initial public offering in 1996.